Legal Representation
Attorney
Carole R. Klein
USPTO Deadlines
Next Deadline
49 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 30, 2025
Application History
37 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 30, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Jun 30, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Feb 28, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 27, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED |
Feb 27, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Nov 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 19, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
May 15, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
May 14, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 14, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
May 14, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
Nov 14, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 10, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
Nov 10, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 10, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
May 16, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
May 12, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
May 12, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
May 12, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 15, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 11, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
Nov 11, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
Nov 11, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 24, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 29, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 29, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 9, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Feb 23, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 20, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 19, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 19, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 12, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jan 12, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jan 12, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
Dec 16, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Aug 25, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jun 5, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 009
Downloadable computer software for use in calculating and tailoring the optimal individualized dosage for patients through blood samples from patients; downloadable computer software for use in mobile applications to develop model-informed precision dosing, track individualized dosing, generate population- and individual-based pharmacokinetic models, monitor clinical studies, determine optimal and lowest effective dosages of medication, develop risk evaluation and mitigation strategies and surveillance system for adverse effects, track status of government approval, and collect real world evidence on value of therapeutic agent
Class 042
Creating, maintaining and hosting an interactive website for others featuring technology that enables users to enter, access, track, and generate health and medical information; creating, maintaining and hosting an interactive website for others featuring technology that enables users to manage chronic diseases, medical conditions, and health risks; creating, maintaining, and hosting an interactive website for others featuring technology that enables users to enter medical information and generate the lowest effective dosage of medication; design and development of software in the field of interactive mobile applications featuring technology that enables users to manage their optimal dosing intervals of medication; Providing temporary use of nondownloadable computer software for use in calculating and tailoring the optimal individualized dosage for patients through blood samples from patients; Providing temporary use of non-downloadable computer software for use in mobile applications to develop model-informed precision dosing, track individualized dosing, generate population- and individual based pharmacokinetic models, monitor clinical studies, determine optimal and lowest effective dosages of medication, develop risk evaluation and mitigation strategies and surveillance system for adverse effects, track status of government approval, and collect real world evidence on value of therapeutic agent
Class 044
Providing an online database featuring medical information and diagnostics in the nature of pharmaceutical information for developing model-informed precision dosing, tracking individualized dosing, generating population based and individual based pharmacokinetic models, monitoring clinical studies, determining optimal and lowest effective dosages of medication, developing risk evaluation and mitigation strategies and surveillance system for adverse effects, and collecting real world evidence on value of therapeutic agent
Class 045
providing an online database featuring tracking the status of government approval of medications
Classification
International Classes
009
042
044
045